Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study

Alzheimer's and Dementia

Volumn 12, Issue 8, 2016, Pages 917-924

  Rattinger, Gail B ^a,b   Fauth, Elizabeth B ^c   Behrens, Stephanie ^c   Sanders, Chelsea ^c   Schwartz, Sarah ^c   Norton, Maria C ^c   Corcoran, Chris ^c   Mullins, C Daniel ^d   Lyketsos, Constantine G ^e   Tschanz, JoAnn T ^c  

^a BINGHAMTON UNIVERSITY   (United States)

^b FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^c UTAH STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^e JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Caregiver; Informal costs of dementia; Relationship closeness

Indexed keywords

ADULT CHILD; AGED; ARTICLE; CARE RECIPIENT RELATIONSHIP; CAREGIVER; CAREGIVER SUPPORT; CONTROLLED STUDY; COPING BEHAVIOR; COST OF ILLNESS; DEMENTIA; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; EMOTION ASSESSMENT; FEMALE; HEALTH CARE COST; HUMAN; HUMAN RELATION; INTIMACY; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; PATIENT CARE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RELATIONSHIP CLOSENESS SCALE; SALARY; SPOUSE; WAYS OF COPING QUESTIONNAIRE; DISEASE COURSE; ECONOMICS; EPIDEMIOLOGY; LONGITUDINAL STUDY; NURSING; PSYCHOLOGY; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAREGIVERS; COST OF ILLNESS; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; UNITED STATES;

EID: 84970028621     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.03.008     Document Type: Article

References (38)

1. [1] Alzheimer's Disease International. World Alzheimer's Report 2012: overcoming the stigma of dementia. 2012, Alzheimer's Disease International, London.
2. [2] Alzheimer's Association. 2015 Alzheimer's facts and figures. 2015, Alzheimer's Association, Chicago, IL.
3. [3] Hill, J., Futterman, R., Duttagupta, S., Mastey, V., Lloyd, J.R., Fillit, H., Alzheimer's disease and related dementias increase costs of co-morbidities in managed Medicare. Neurology 58 (2002), 62–70.
4. [4] Zhu, C.W., Scarmeas, N., Torgan, R., Albert, M., Brandt, J., Blacker, D., et al. Clinical characteristics and longitudinal changes of informal costs of Alzheimer's disease in the community. J Am Geriatr Soc 54 (2006), 1596–1602.
5. [5] Taylor, D.H., Ostbye, T., Langa, K.M., Weir, D., Plassman, B.L., The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis 17 (2009), 807–815.
6. [6] Lacey, L., Niecko, T., Leibman, C., Liu, E., Grundman, M., Group E-A-I. Association between illness progression measures and total cost in Alzheimer's disease. J Nutr Health Aging 17 (2013), 745–750.
7. [7] Leicht, H., Heinrich, S., Heider, D., Bachmann, C., Bickel, H., van den Bussche, H., et al. Net costs of dementia by disease stage. Acta Psychiatr Scand 124 (2011), 384–395.
8. [8] Andersen, C.K., Lauridsen, J., Andersen, K., Kragh-Sorensen, P., Cost of dementia: impact of disease progression estimated in longitudinal data. Scand J Public Health 31 (2003), 119–125.
9. [9] Zhu, C.W., Leibman, C., McLaughlin, T., Zbrozek, A.S., Scarmeas, N., Albert, M., Patient dependence and longitudinal changes in costs of care in Alzheimer's disease. Dement Geriatr Cogn Disord 26 (2008), 416–423.
10. [10] Hurd, M., Martorell, P., Delavande, A., Mullen, K., Langa, K.M., Monetary costs of dementia in the United States. N Engl J Med 368 (2013), 1326–1334.
11. [11] Tschanz, J.T., Corcoran, C.D., Schwartz, S., Treiber, K., Green, R.C., Norton, M.C., et al. Progression of cognitive, functional, and neuropsychiatric symptoms in a population cohort with Alzheimer dementia: the Cache County Dementia Progression Study. Am J Geriatr Psychiatry 19 (2011), 532–542.
12. [12] Rattinger, G.B., Schwartz, S., Mullins, C.D., Corcoran, C.D., Zuckerman, I.H., Sanders, C., et al. Dementia severity and the longitudinal costs of informal care in the Cache County population. Alzheimers Dement 11 (2015), 946–954.
13. [13] Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975), 189–198.
14. [14] Morris, J.C., The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (1993), 2412–2414.
15. [15] Cummings, J.L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D.A., Gornbein, J., The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994), 2308–2314.
16. [16] Norton, M.C., Piercy, K.W., Rabins, P.V., Green, R.C., Breitner, J.C., Østbye, T., et al. Caregiver–recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci 64 (2009), 560–568.
17. [17] Tschanz, J.T., Piercy, K., Corcoran, C.D., Fauth, E., Norton, M.C., Rabins, P.V., et al. Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study. Am J Geriatr Psychiatry 21 (2013), 57–66.
18. [18] Breitner, J.C., Wyse, B.W., Anthony, J.C., Welsh-Bohmer, K.A., Steffens, D.C., Norton, M.C., et al. APOE-E4 count predicts age when prevalence of AD increases, then declines. Neurology 53 (1999), 321–331.
19. [19] Miech, R.A., Breitner, J.C., Zandi, P.P., Khachaturian, A.S., Anthony, J.C., Mayer, L., Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology 58 (2002), 209–218.
20. [20] Diagnostic and statistical manual of mental disorders, 3rd Revised ed., 1987, American Psychiatric Association, Washington, DC.
21. [21] McKhann, G., Drachman, D., Folstein, M.F., Katzman, R., Price, D., Stadlan, E., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984), 939–944.
22. [22] Roman, G.C., Tatemichi, T., Erkinjuntti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993), 250–260.
23. [23] CDR overview & abstracts, 2011, University School of Medicine, Washington.
24. [24] Lyketsos, C.G., Galik, E., Steele, C., Steinberg, M., Rosenblatt, A., Warren, A., et al. The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc 47 (1999), 487–491.
25. [25] Zhu, C.W., Scarmeas, N., Torgan, R., Albert, M., Brandt, J., Blacker, D., et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology 67 (2006), 998–1005.
26. [26] Penrod, J.D., Kane, R.L., Finch, M.D., Kane, R.A., Effects of post hospital Medicare home health and informal care on patient functional status. Health Serv Res 33 (1998), 513–529.
27. [27] Occupational employment and wage estimates, 2013, Bureau of Labor Statistics Available at: http://www.bls.gov/oes/. Accessed April 20, 2016.
28. [28] Noelker, L.S., Promoting positive relationships between nursing assistants and the families of cognitively impaired nursing home residents. Final report to the Cleveland Foundation. 1996, A Benajamin Rose Institute, Cleveland, OH.
29. [29] Whitlach, C.J., Schur, D., Noelker, L.S., Ejaz, F.K., Looman, W.J., The stress process of family caregiving in institutional settings. Gerontologist 41 (2001), 462–473.
30. [30] Fauth, E., Hess, K., Piercy, K., Norton, M., Corcoran, C., Rabins, P., et al. Caregivers' relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers' physical health and psychological well-being. Aging Ment Health 16 (2012), 699–711.
31. [31] Vitaliano, P.P., Russo, J., Carr, J.E., Maiuro, R.D., Becker, J., The ways of coping checklist: Revision and psychometric properties. Multivariate Behav Res 20 (1985), 3–26.
32. [32] Lawrence, R.H., Tennstedt, S.L., Assmann, S.F., Quality of the caregiver–care recipient relationship: does it offset negative consequences of caregiving for family caregivers?. Psychol Aging 13 (1998), 150–158.
33. [33] Blieszner, R., de Vries, B., Perspectives on intimacy. Generations 25 (2001), 7–8.
34. [34] McDaid, D., Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges. Int J Geriatr Psychiatry 16 (2001), 400–405.
35. [35] Treiber, K.A., Carlson, M.C., Corcoran, C., Norton, M.C., Breitner, J.C., Piercy, K.W., et al. Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci 66 (2011), 416–425.
36. [36] Mielke, M.M., Rosenberg, P.B., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., et al. Vascular factors predict rate of progression in Alzheimer's disease. Neurology 69 (2007), 1850–1858.
37. [37] Rosenberg, P.B., Mielke, M.M., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., et al. Effects of cardiovascular medications on rate of functional decline in Alzheimer's disease. Am J Geriatr Psychiatry 16 (2008), 883–892.
38. [38] Mielke, M.M., Leoutsakos, J.M., Corcoran, C.D., Green, R.C., Norton, M.C., Welsh-Bohmer, K.A., et al. Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. Alzheimers Dement 8 (2012), 180–187.